Back to search

Article

<em>Trypanosoma cruzi</em> STIB980: A TcI Strain for Drug Discovery and Reverse Genetics

2023-08-31

Abstract excerpt

Since the first published genome sequence of Trypanosoma cruzi in 2005, there has been tremendous technological advance in genomics, reverse genetics, and assay development for this elusive pathogen. However, there is still an unmet need for new and better drugs to treat Chagas disease. Here we introduce a T. cruzi assay strain that is useful for drug research as well as basic studies in host-pathogen interaction....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5056d347-866b-56a4-83e1-d9d51f57a039
DOI
10.20944/preprints202308.2120.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<em>Trypanosoma cruzi</em> STIB980: A TcI Strain for Drug Discovery and Reverse GeneticsDOI 10.20944/preprints202308.2120.v1
Select a neighboring publication to make it the new centre.